Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOPKO Health, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.12 | -$0.04 | -$0.08 |
| Q2 2025 | 2 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 2 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2025 | 2 | -$0.07 | -$0.06 | -$0.07 |
| Q1 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
OPKO Health, Inc. Earnings Date And Information
OPKO Health, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1 by $0.13. The company had revenue of 173.63 M for the quarter and had revenue of 863.50 M for the year. OPKO Health, Inc. has generated $0 earnings per share over the last year ($-0.25 diluted earnings per share) and currently has a price-to-earnings ratio of -7.53. OPKO Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
OPKO Health, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.10 | $0.04 | 0.14 | $181.52 M | $173.63 M |
| 08/07/2024 | Q2 2024 | -$0.09 | -$0.01 | 0.08 | $184.70 M | $182.19 M |
| 05/07/2024 | Q1 2024 | -$0.09 | -$0.12 | -0.03 | $173.69 M | |
| 03/01/2024 | Q4 2023 | -$0.09 | $181.90 M | |||
| 11/06/2023 | Q3 2023 | -$0.09 | -$0.11 | -0.02 | $174.78 M | $178.60 M |
| 08/03/2023 | Q2 2023 | -$0.07 | -$0.03 | 0.04 | $201.97 M | $265.42 M |
| 05/03/2023 | Q1 2023 | -$0.07 | -$0.02 | 0.05 | $237.60 M | |
| 02/27/2023 | Q4 2022 | -$0.11 | $185.40 M | |||
| 11/08/2022 | Q3 2022 | -$0.10 | -$0.11 | -0.01 | $183.51 M | $179.74 M |
| 08/04/2022 | Q2 2022 | -$0.00 | -$0.14 | -0.14 | $326.87 M | $309.89 M |
| 05/09/2022 | Q1 2022 | -$0.08 | -$0.08 | -0 | $329.22 M | |
| 03/01/2022 | Q4 2021 | -$0.11 | $401.30 M | |||
| 10/28/2021 | Q3 2021 | $0.02 | $0.04 | 0.02 | $302.27 M | $385.81 M |
| 07/29/2021 | Q2 2021 | -$0.01 | -$0.03 | -0.01 | $456.36 M | $442.41 M |
| 04/28/2021 | Q1 2021 | $0.05 | $0.05 | 0 | $545.17 M | |
| 02/18/2021 | Q4 2020 | $0.04 | $0.05 | 0.01 | $494.60 M | |
| 10/29/2020 | Q3 2020 | $0.04 | $0.04 | -0 | $378.66 M | $428.06 M |
| 07/31/2020 | Q2 2020 | $0.05 | $245.60 M | $301.21 M | ||
| 05/06/2020 | Q1 2020 | -$0.09 | -$0.09 | -0 | $211.47 M | |
| 03/02/2020 | Q4 2019 | -$0.18 | $224.30 M |
OPKO Health, Inc. Earnings: FAQ's
When is OPKO Health, Inc.'s earnings date?
OPKO Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
Did OPKO Health, Inc. beat their earnings estimates last
quarter?
In the previous quarter, OPKO Health, Inc. (:OPK) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1 by $0.13.
How can I listen to OPKO Health, Inc.'s earnings conference
call?
The conference call for OPKO Health, Inc.'s latest earnings report can be listened to online.
How can I read OPKO Health, Inc.'s conference call transcript?
The conference call transcript for OPKO Health, Inc.'s latest earnings report can be read online.
How much revenue does OPKO Health, Inc. generate each year?
OPKO Health, Inc. (:OPK) has a recorded annual revenue of $863.50 M.
How much profit does OPKO Health, Inc. generate each year?
OPKO Health, Inc. (:OPK) has a recorded net income of $863.50 M. OPKO Health, Inc. has generated $-0.25 earnings per share over the last four quarters.
What is OPKO Health, Inc.'s price-to-earnings ratio?
OPKO Health, Inc. (:OPK) has a price-to-earnings ratio of -7.53 and price/earnings-to-growth ratio is -0.18.